Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)

Research Square(2022)10.21203/rs.3.rs-2175808/v1Source: DataRank Database

The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1) is a research paper published in Research Square (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (31)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Hope Waisner ORCID,Sachith Polpitiya Arachchige,Maria Kalamvoki ORCID,Edward B. Stephens ORCID,Wyatt Henke

Live enrichment

PubMed:36324807 OpenAlex:https://openalex.org/W4307275346

National Institutes of Health

Grant: 1R21AI158229-01

Immunomodulatory effects of coronavirus membrane proteins E, M, and S.

National Institutes of Health

Grant: 5UL1TR002366-04

Frontiers: University of Kansas Clinical and Translational Science Institute

NIAID NIH HHS

Grant: R21 AI158229

greenLicense: cc-by

repositoryhttps://www.researchsquare.com/article/rs-2175808/latest.pdf

publisherhttps://www.researchsquare.com/article/rs-2175808/v1

publisherhttps://www.researchsquare.com/article/rs-2175808/v1.html

repositoryhttps://doi.org/10.21203/rs.3.rs-2175808/v1

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral Infections and Immunology Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

VirologyInfectivitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Human immunodeficiency virus (HIV)Sars virusBiologyEnvelope (radar)Coronavirus2019-20 coronavirus outbreakVirusCoronavirus disease 2019 (COVID-19)MedicineComputer scienceInternal medicineSARS-CoV-2ResearchCOVID-19RC581-607Virus ReplicationArticleViroporin ProteinsHIV-1HumansImmunologic diseases. AllergyAmino Acids

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)

FAIR Checklist

Authors (5)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)